Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-26

Clinical Trial Update: Single or Repeated Intravenous Administration of umbiliCAl Cord Mesenchymal sTrOmal Cells in Ischemic Cardiomyopathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating single or repeated intravenous administration of umbilical cord mesenchymal stromal cells for ischemic heart disease/ischemic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Umbilical Cord Mesenchymal Stromal Cells (umbilical cord mesenchymal stromal cells)

Snippet

Sponsor: Roberto Bolli | Conditions: Ischemic Heart Disease | Phase 2 | Status: RECRUITING